Citadel Advisors LLC 13D and 13G filings for Edgewise Therapeutics, Inc.:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
- Shares have been adjusted for stock splits.
| Reported DateTime | Transaction Date | Type | Company Symbol | Filed By Symbol | Shares Owned % Owned | Shares Vs. Prev Report | View |
| 2023-02-14 08:14 am Purchase | 2022-12-31 | 13G | Edgewise Therapeutics, Inc. EWTX | Citadel Advisors LLC | 2,849,354 4.500% | 360,070 (+14.46%) | Filing |
| 2022-01-13 4:28 pm Purchase | 2022-01-03 | 13G | Edgewise Therapeutics, Inc. EWTX | Citadel Advisors LLC | 2,489,284 5.000% | 30,761 (+1.25%) | Filing |
| 2022-01-13 4:27 pm Purchase | 2021-12-31 | 13G | Edgewise Therapeutics, Inc. EWTX | Citadel Advisors LLC | 2,458,523 5.000% | 3,199 (+0.13%) | Filing |
| 2021-07-12 4:07 pm Purchase | 2021-07-01 | 13G | Edgewise Therapeutics, Inc. EWTX | Citadel Advisors LLC | 2,455,324 5.000% | 2,455,324 (New Position) | Filing |